ALK and neuroblastoma: We noted, however, that ALK amplification frequencies at relapse were significantly elevated in patients <18 months with stage 4 disease as compared to patients ≥18 months with stage 4 neuroblastoma (16.7% versus 2.9%, P = 0.041, Fig. 3c).